Indication
Familial Mediterranean Fever
5 clinical trials
5 products
Product
RIST4721Clinical trial
An Open-label, Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of RIST4721 in Subjects With Familial Mediterranean FeverStatus: Withdrawn, Estimated PCD: 2023-11-30
Product
RPH-104Clinical trial
International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of ColchicineStatus: Recruiting, Estimated PCD: 2024-08-01
Product
PlaceboClinical trial
An International Multicenter Open-label Clinical Study of the Safety and Efficacy of RPH-104 for Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of ColchicineStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily TherapyStatus: Not yet recruiting, Estimated PCD: 2026-03-03
Product
ANAKINRAClinical trial
Study Of Colchicine Resistance In Familial Mediterranean FeverStatus: Completed, Estimated PCD: 2023-07-04
Product
Capillary colchicine